Transcripts Syntara Limited

Actions

SNT

AU0000312480

Recherche biotechnologique et médicale

Cours en clôture Australian S.E. Autres places de cotation 31/07/2026			Varia. 5j.	Varia. 1 janv.
0,0255 ^AUD	+15,91%		+15,91%	-27,14%

28/07	Transcript : Syntara Limited, Q4 2026 Earnings Call, Jul 28, 2026
07/07	Le candidat-médicament de Syntara contre Parkinson affiche des résultats d'essais encourageants, selon Euroz Hartleys	MT

Transcripts

28/07	Transcript : Syntara Limited, Q4 2026 Earnings Call, Jul 28, 2026
06/07	Transcript : Syntara Limited - Special Call
23/06	Transcript : Syntara Limited - Shareholder/Analyst Call
01/06	Transcript : Syntara Limited - Shareholder/Analyst Call
30/04	Transcript : Syntara Limited - Shareholder/Analyst Call
03/02	Transcript : Syntara Limited - Special Call
26/11	Transcript : Syntara Limited - Special Call
20/11	Transcript : Syntara Limited - Shareholder/Analyst Call
30/09/25	Transcript : Syntara Limited - Shareholder/Analyst Call
14/08/25	Transcript : Syntara Limited - Shareholder/Analyst Call
01/08/25	Transcript : Syntara Limited, Q4 2025 Earnings Call, Aug 01, 2025
13/06/25	Transcript : Syntara Limited - Special Call
01/05/25	Transcript : Syntara Limited, Q3 2025 Earnings Call, May 01, 2025
18/03/25	Transcript : Syntara Limited - Special Call
17/02/25	Transcript : Syntara Limited - Shareholder/Analyst Call
10/12/24	Transcript : Syntara Limited - Special Call
28/11/24	Transcript : Syntara Limited - Shareholder/Analyst Call
30/10/24	Transcript : Syntara Limited, Q1 2025 Earnings Call, Oct 30, 2024
20/09/24	Transcript : Syntara Limited - Shareholder/Analyst Call
13/06/24	Transcript : Syntara Limited Presents at MST Access 'Hidden Gems in Life Sciences' Webinar, Jun-13-2024 02:30 PM
30/04/24	Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024
31/01/24	Transcript : Syntara Limited - Shareholder/Analyst Call
31/10/23	Transcript : Pharmaxis Ltd, Q1 2024 Earnings Call, Oct 31, 2023
03/10/23	Transcript : Pharmaxis Ltd - Special Call
31/07/23	Transcript : Pharmaxis Ltd, Q4 2023 Earnings Call, Jul 31, 2023